These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27432098)

  • 1. Fluctuation in Serum Sodium Levels Related to Ipragliflozin Administration in a Patient with Diabetic Nephropathy and Sequela of Traumatic Brain Injury.
    Okonogi H; Harada M; Sato H; Tokoro K; Nakayama I; Tsuboi N; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
    Intern Med; 2016; 55(14):1887-91. PubMed ID: 27432098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sodium balance impairment in a child with severe traumatic brain injury].
    Aleksandrovich YS; Pshenisnov KV; Ustinova AS; Kopylov VV; Aleksandrovich IV; Gordeev VI
    Probl Endokrinol (Mosk); 2019 May; 65(1):39-45. PubMed ID: 31091049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the SGLT2 inhibitor ipragliflozin on various diabetic symptoms and progression of overt nephropathy in type 2 diabetic mice.
    Tahara A; Takasu T
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):395-406. PubMed ID: 29374293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice.
    Tahara A; Takasu T
    Eur J Pharmacol; 2018 Jul; 830():68-75. PubMed ID: 29702076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First case of drug eruption due to ipragliflozin: Case report and review of the literature.
    Saito-Sasaki N; Sawada Y; Nishio D; Nakamura M
    Australas J Dermatol; 2017 Aug; 58(3):236-238. PubMed ID: 27242192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor.
    Miyauchi M; Toyoda M; Fukagawa M
    Intern Med; 2017; 56(13):1673-1678. PubMed ID: 28674356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats.
    Tahara A; Kurosaki E; Yokono M; Yamajuku D; Kihara R; Hayashizaki Y; Takasu T; Imamura M; Li Q; Tomiyama H; Kobayashi Y; Noda A; Sasamata M; Shibasaki M
    J Pharm Pharmacol; 2014 Jul; 66(7):975-87. PubMed ID: 24533859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with ipragliflozin and metformin: a randomized, double-blind, placebo-controlled study in patients with type 2 diabetes mellitus.
    Veltkamp SA; van Dijk J; Collins C; van Bruijnsvoort M; Kadokura T; Smulders RA
    Clin Ther; 2012 Aug; 34(8):1761-71. PubMed ID: 22795925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tofogliflozin 20 mg and ipragliflozin 50 mg used together with insulin glargine 300 U/mL using continuous glucose monitoring (CGM): A randomized crossover study.
    Takeishi S; Tsuboi H; Takekoshi S
    Endocr J; 2017 Oct; 64(10):995-1005. PubMed ID: 28824042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced Liver injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report.
    Niijima K; Niijima Y; Okada S; Yamada M
    Ann Hepatol; 2017; 16(2):308-311. PubMed ID: 28233736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic and antiobesity effects of SGLT2 inhibitor ipragliflozin in type 2 diabetic mice fed sugar solution.
    Tahara A; Takasu T; Yokono M; Imamura M; Kurosaki E
    Eur J Pharmacol; 2018 Jan; 818():545-553. PubMed ID: 29154936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyponatremia secondary to multiple etiologies: a case report.
    Kamoi K; Soda S; Sasaki H
    J Med; 2004; 35(1-6):125-40. PubMed ID: 18084871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyponatremia in Traumatic Brain Injury: A Practical Management Protocol.
    Rajagopal R; Swaminathan G; Nair S; Joseph M
    World Neurosurg; 2017 Dec; 108():529-533. PubMed ID: 28899834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early inhibition of natriuresis suppresses symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Nakagawa I; Hironaka Y; Nishimura F; Takeshima Y; Matsuda R; Yamada S; Motoyama Y; Park YS; Nakase H
    Cerebrovasc Dis; 2013; 35(2):131-7. PubMed ID: 23406891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effect of a mineralocorticoid in patients with hyponatremia of central origin].
    Morinaga K; Hayashi S; Matsumoto Y; Omiya N; Mikami J; Sato H; Inoue Y; Okawara S; Ishimaru K
    No To Shinkei; 1995 Jul; 47(7):671-4. PubMed ID: 7612384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosuria medicated with ipragliflozin and nifedipine or ipragliflozin and candesartan: a case report.
    Okada S; Shibusawa R; Tagaya Y; Saito T; Yamada E; Shimoda Y; Satoh T; Okada J; Yamada M
    J Med Case Rep; 2014 Dec; 8():428. PubMed ID: 25515334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatremia responsive to fludrocortisone acetate in elderly patients after head injury.
    Ishikawa SE; Saito T; Kaneko K; Okada K; Kuzuya T
    Ann Intern Med; 1987 Feb; 106(2):187-91. PubMed ID: 3800181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Improvement of the Hepatic Histological Findings in a Patient with Non-alcoholic Steatohepatitis with Type 2 Diabetes after the Administration of the Sodium-glucose Cotransporter 2 Inhibitor Ipragliflozin.
    Takeda A; Irahara A; Nakano A; Takata E; Koketsu Y; Kimata K; Senda E; Yamada H; Ichikawa K; Fujimori T; Sumida Y
    Intern Med; 2017 Oct; 56(20):2739-2744. PubMed ID: 28924123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebral salt wasting syndrome secondary to head injury: a case report].
    Kawajiri K; Matsuoka Y; Kan M
    No Shinkei Geka; 1992 Sep; 20(9):1003-7. PubMed ID: 1407351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of Ipragliflozin in Patients with Steroid-Induced Hyperglycemia during Cancer Chemotherapy].
    Horasawa S; Osame K; Kawasumi K; Saito S; Bando H; Ohashi K
    Gan To Kagaku Ryoho; 2016 May; 43(5):645-7. PubMed ID: 27210101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.